Form 4: Cadre Holdings Director Granted 16,000 Stock Options Under 2021 Incentive Plan

Cadre Holdings, Inc. Director Gianmaria C. Delzanno was granted 16,000 stock options with an exercise price of $32.77, vesting quarterly through March 2026.

Summary

• Gianmaria C. Delzanno, a Director of Cadre Holdings, Inc. (CDRE), was granted 16,000 stock options.
• The options have an exercise price of $32.77 per share.
• The grant date for these options was May 30, 2025.
• The options were granted under the Issuer's 2021 Stock Incentive Plan.
• The options will vest in four equal quarterly tranches of 4,000 shares each, starting on June 30, 2025, followed by September 30, 2025, December 31, 2025, and finally March 31, 2026.
• The expiration date for these stock options is May 30, 2035.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the grant of stock options aligns the director's interests with shareholders and is a standard, expected compensation practice, indicating stability in governance and incentive structures.

Positives

• The grant of stock options to a director aligns their financial interests with the long-term performance and shareholder value of Cadre Holdings, Inc.
• The options are part of a structured incentive plan, indicating a commitment to performance-based compensation for key personnel.

Future Outlook

The stock option grant with a multi-year vesting schedule indicates a forward-looking incentive for the director to contribute to the company's long-term growth and performance, aligning with the objectives of the 2021 Stock Incentive Plan.

Industry Context

The granting of stock options to directors is a common practice in publicly traded companies across various industries, serving as a key component of executive and director compensation packages designed to align leadership interests with shareholder returns.

Comparison to Industry Standards

• Stock option grants are a standard form of equity compensation for directors and executives in publicly traded companies, comparable to practices seen in other firms within the security and defense industry.
• The vesting schedule over approximately one year is a typical approach to encourage retention and long-term performance, similar to incentive structures at companies like Axon Enterprise (AXON) or Smith & Wesson Brands (SWBI) for their leadership.

Corporate Governance

Related Party Transactions

• The grant of stock options to Gianmaria C. Delzanno, a Director of Cadre Holdings, Inc., constitutes a related party transaction as it involves compensation provided by the company to a member of its board of directors.

Stakeholder Impact

• Shareholders: The grant of stock options aims to align the director's interests with shareholders by incentivizing long-term stock price appreciation.
• Employees: While not directly impacting general employees, such compensation practices for leadership can set a precedent for performance-based incentives within the company.

Next Steps

• The vesting of 4,000 shares of common stock on June 30, 2025.
• Subsequent quarterly vesting tranches on September 30, 2025, December 31, 2025, and March 31, 2026.

Key Dates

Recommendation

Keywords

Cadre Holdings, CDRE, Stock Options, Form 4, Insider Transaction, Executive Compensation, Equity Grant, Director Compensation, Incentive Plan